Browse the collection
Wegovy (Semaglutide) Injections
Start your consultation on the condition page to check your eligibility.
Weight loss is a key goal for many people in Europe seeking to achieve optimal health and well-being. It involves the intentional reduction of excess body fat through a strategic combination of dietary changes, increased physical activity, and significant lifestyle adjustments. Beyond its aesthetic aspects, achieving a healthy weight is essential for preventing and managing a range of obesity-related health problems, thus improving overall quality of life.
Calculate your BMI and daily calorie needs for your weight loss journey.
To begin, you will complete a secure online questionnaire that gathers essential information about your health and weight loss goals. This allows our licensed healthcare professionals to assess your eligibility for treatment. Once the questionnaire is submitted, your answers will be carefully reviewed, and if necessary, a clinician may contact you with further questions. If approved, a prescription will be issued and your treatment will be shipped from our EU-based pharmacy.
No appointment is necessary. The consultation is completely flexible and can be completed at any time, at your convenience. You can pause the form and return to it whenever you wish. Once submitted, one of our healthcare professionals will review it within 24 hours. If, for any reason, you do not receive a response within this time, simply contact us at info@medetone.com and we will respond promptly.
The online consultation is completely free. You only pay if you are approved for treatment. If you are not eligible, your payment will be fully refunded. You can also discuss with a clinician beforehand, without obligation, to determine which weight loss treatment is best suited to your needs.
The newest treatment approved for weight loss and type 2 diabetes.
Contains tirzepatide, a drug that targets two key hormones: GLP-1 and GIP.
This dual-action mechanism not only reduces appetite, but also improves blood sugar control.
Designed to improve results when combined with lifestyle changes.
Approved for weight management in overweight or obese adults.
Contains semaglutide, a GLP-1 receptor agonist.
It mimics a natural hormone that acts on the appetite control centers in the brain.
Helps reduce hunger and calorie intake, promoting sustainable weight loss.
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Main Use | Weight management | Weight management and diabetes |
| Active Ingredient | Semaglutide | Tirzepatide |
| Mechanism | GLP-1 receptor | GLP-1 + GIP receptors |
| Approved for Weight Loss? | ✓ Yes | ✓ Yes |
| Clinical Results | Up to 17% weight loss¹ | Up to 21% weight loss³ |
Although oral and injectable weight-loss medications may contain the same active ingredient (such as semaglutide), they are chemically designed to suit their method of administration. Injectables go directly into the bloodstream, while oral forms must survive the digestive system—therefore their formulas differ to ensure their effectiveness.
Key differences:
Oral weight-loss medications can be effective, but they don't always work exactly the same way as injections. Even when the active ingredient is identical, oral versions are absorbed differently by the body—which can slightly influence the amount of medication actually available to work.
That being said, for some people, oral options represent a more practical and still clinically effective alternative.
Key points:
